Pfau, M
[Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. [electronic resource]
- Klinische Monatsblatter fur Augenheilkunde 08 2016
- e3 p. digital
Publication Type: Journal Article; Published Erratum
1439-3999
10.1055/s-0042-115798 doi